Recruiting
Living Well With Advanced Breast Cancer
This study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they still need.
ClinicalTrials.gov IDNCT07227038
PhaseNot Applicable
Enrollment50
SponsorOhio State University Comprehensive Cancer Center
Age18 Years
SexALL
Conditions studied
Advanced Breast Carcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
About this study
This study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they still need.
Interventions
- Other: Non-Interventional Study — Non-interventional study
Primary outcomes
- Acceptability of current LWABC (Living Well with Advanced Breast Cancer) model (Up to study completion, up to 1 day)
- Participant medical history, treatment records, and demographic data (Up to study completion, up to 1 day)
- Differences in survivorship care engagement across four distinct cohorts (Up to study completion, up to 1 day)
Eligibility information
Inclusion Criteria:
* \* COHORT 1:
* Diagnosis of stage 4 metastatic breast cancer within the past 5 years
* Never been referred to the LWABC
* Adults age ≥ 18 years
* COHORT 2:
* Diagnosis of stage 4 metastatic breast cancer within the past 5 years
* Have cancelled an appointment with the LWABC
* Adults age ≥ 18 years
* COHORT 3:
* Been seen in the Medical Oncology Clinic at Stephanie Spielman Comprehensive Breast Center (SSCBC) within the past 5 years
* Completed an appointment with the LWABC
* Adults age ≥ 18 years
* COHORT 4:
* Caregivers for ABC patients
* Adults age ≥ 18 years
Exclusion Criteria:
* Patients who cannot provide own informed consent
Study locations
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.